Desmoplakin Cardiomyopathy Presenting as Recurrent Myocarditis Treated With Immunosuppression
Jacob Abdaem1, Nathan Leader2, Brennan A Ballantyne3
1Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.
JACC. Case Reports
|August 6, 2025
Summary
Desmoplakin (DSP) cardiomyopathy, a genetic heart condition, can present with inflammation. A novel DSP variant was identified, leading to a proposed management algorithm including immunosuppression and heart failure therapies.
Area of Science:
- Cardiology
- Genetics
- Immunology
Background:
- Desmoplakin (DSP) cardiomyopathy is a genetic disorder.
- It is associated with myocarditis, heart failure, and sudden cardiac death.
Observation:
- A patient presented with palmoplantar keratoderma, recurrent myocarditis, and cardiac inflammation.
- Genetic testing revealed a novel heterozygous DSP truncating variant (c.123C>G, p.Tyr41*).
- Immunosuppression with prednisone and mycophenolate mofetil improved cardiac inflammation.
Findings:
- A novel DSP truncating variant linked to inflammatory cardiomyopathy was identified.
- The variant was also found in the patient's sister, who had occult cardiomyopathy and myocardial fibrosis.
- The proposed algorithm incorporates predictive testing, immunosuppression, risk stratification, and heart failure management.
Implications:
- This study identifies a new DSP variant associated with inflammatory cardiomyopathy.
- The proposed management algorithm offers a structured approach to treating DSP cardiomyopathy.
- Early diagnosis and intervention, including immunosuppression and heart failure therapy, may improve patient outcomes.
Related Concept Videos
Myocarditis I: Introduction
30
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
30
Myocarditis III: Medical Management
16
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy
31
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
31
Myocarditis II: Clinical Features and Diagnostic Tests
21
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
21
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Cardiomyopathy I: Introduction and Classification
56
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
56


